Welcome to MS Views and News blog


MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

September 17, 2020

Registration open for our next Virtual ‘Compass to MS Care’ Rural America and Beyond, event – on 9/22/20

  • #COVID-19
    /
  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
  • SPMS-PPMS News
    /
RSVP , by clicking here, for: A Compass to MS Care event on 9/22 at 6:10pm ET — with Dr.…
#COVID-19

September 17, 2020

Does obesity exacerbate brain lesion volume and atrophy in patients with multiple sclerosis?

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
Click HERE to Subscribe for the MS Beacon Newsletter Rachel Galioto 1, Ophira Berenholz 2, Zhini Wang 3, Devon S Conway 4, Sarah M Planchon 4, Stephen M Rao 5 Affiliations expand…
MS Research Study and Reports

September 16, 2020

Bristol-Myers Squibb works to achieve the mission of transforming patients’ lives through science. Introducing a Patient Expert Engagement Resource (PEER)

  • Additional MS resource sites
    /
  • Multiple Sclerosis
    /
  • Multiple Sclerosis Videos
    /
 BMS.com would like to share a new article and video highlighting Patient Expert Engagement Resource (PEER) and featuring quotes and footage from…
Additional MS resource sites

September 14, 2020

Video Game Treatment May Improve Cognitive Function, Study Shows

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
  • An MS Patients Story
    /
August 25, 2020 By Trevis Gleason New research indicates that a novel, video-game-style intervention  may be beneficial to people with MS…
Alternative therapies and devices for Multiple Sclerosis (MS)

September 13, 2020

More on the FDA Approval of Kesimpta, B-cell Targeting Therapy for Relapsing MS

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
The U.S. Food and Drug Administration (FDA) has approved Novartis‘ Kesimpta (ofatumumab) as a self-administered treatment for adults with relapsing forms of multiple sclerosis (MS),…
MS Drug Therapies

September 13, 2020

New Data Further Reinforce Genentech’s Ocrevus (ocrelizumab) as a Highly Effective Treatment for People With Multiple Sclerosis

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
  • Ocrevus
    /
* 75% of patients with relapsing-remitting multiple sclerosis (RRMS) and suboptimal response to prior treatment had no evidence of disease…
MS Drug Therapies

September 13, 2020

What Does MS Fatigue Feel Like?

  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
Members of MyMSTeam describe chronic, profound fatigue that does not usually improve with a nap or a cup of coffee.…
Multiple Sclerosis

September 12, 2020

Cognitive Function Testing for Multiple Sclerosis: Why Do It? And When?

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
  • Multiple Sclerosis (MS) Symptoms
    /
Memory problems, slowed thinking, and mental fatigue are common in people with MS. Cognitive testing can identify problems so solutions…
Alternative therapies and devices for Multiple Sclerosis (MS)

September 12, 2020

What’s the Plan for People With MS, Post-COVID-19 Pandemic?

  • An MS Patients Story
    /
  • For the Benefit of the Patient
    /
  • Multiple Sclerosis
    /
As much of the world is trying to find a way to reopen, people with disabilities are being left behind.…
An MS Patients Story

September 11, 2020

Boxed In: COVID-19 and Your Mental Health

  • #COVID-19
    /
  • Additional MS resource sites
    /
  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
  • Mental Health
    /
From #Everyday Health Experts share their insights on managing mental and emotional health in the shadow of the coronavirus pandemic.…
#COVID-19

Categories

Latest Blog Posts